ZSP1601 / Guangdong Zhongsheng Pharma 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ZSP1601 / Guangdong Zhongsheng Pharma
NCT05692492: A Randomized, Double-blind, Placebo-controlled Study of ZSP1601 in Adult Subjects With Nonalcoholic Steatohepatitis (NASH)

Recruiting
2b
180
RoW
ZSP1601, Placebo
Guangdong Raynovent Biotech Co., Ltd
Nonalcoholic Steatohepatitis (NASH)
06/26
12/26

Download Options